Thus, the increase in cancer cell apoptosis upon collateral deletion of genes in the PAPSS2-PTEN locus can be exploited in treatment strategies through a targeted co-deletion of ATAD1 and PTEN (Winter et al, 2021Preprint). Here, PAPSS2 is linked to cancer.